MPhA News

Small Doses

April 13, 2018
News from MPhA
MPhA Events

Minnesota News
National News

News from MPhA

Mission Moments:

UMN College of Pharmacy Faculty on the National Stage

Kristin Janke, PhD, professor in the University of Minnesota College of Pharmacy’s Department of Pharmaceutical Care & Health Systems and director of the Wulling Center for Innovation and Scholarship in Pharmacy Education, will receive the 2018 Distinguished Teaching Scholar Award from the American Association of Colleges of Pharmacy. This award from her peers recognizes her as a gifted teacher, scholar and academic leader.

Amy Pittenger, PharmD, MS, PhD, spoke earlier this week at the National Sex and Gender Health Education Summit. Dr. Pittenger, who is an associate professor in the Department of Pharmaceutical Care & Health Systems and director of the Interprofessional Education and Pharmacy Learning Collaborative at the College of Pharmacy, spoke about competencies in pharmacy education and interesting sex and gender health professional education.

Amy Pittenger

Editor’s Note: During our Annual Learning Networking Event in September, MPhA made note of Mission Moments — those times when a member clearly exemplified our mission to advance patient care. As we move through the year, we will continue to showcase these Mission Moments as part of Small Doses. If you have an example to share, please send it to Laurie Pumper lauriep@mpha.org.

LicenseTrak

Minnesota News

MPSA Annual Fundraiser Set for April 27

MPSA is a non-profit organization comprised of more than 400 University of Minnesota College of Pharmacy students. The organization is committed to the advancement of the pharmacy profession and the development of student pharmacists by providing extracurricular opportunities that foster professional engagement. The funds raised from the MPSA annual auction will go toward professional development opportunities for pharmacy students and sponsorship of health care related community outreach events in Minnesota.

MPSA members provide community outreach through several service projects across Minnesota and internationally. All screenings and services are provided to patients free of charge and include:

  1. Glucose monitoring
  2. Cholesterol checks
  3. Blood pressure readings
  4. Influenza vaccination clinics
  5. Medication safety presentations in local schools and churches
  6. Diabetes screenings and counseling
  7. Education on appropriate over-the-counter medication use and medication adherence

More information about the specifics of the auction and MPSA can be found at www.mnpharmacy.org.

The Auction will be held on Friday, April 27 starting at 6:30 p.m. at The Campus Club at the Minneapolis East Bank campus. If you or your colleagues want to attend this event and/or donate to MPSA, please complete the RSVP form.

MPhA Events

Register Now for Next Week’s MPhA Virtual Coffee Break on Pharmacist Workforce Issues

Wednesday, April 18, 2018 • 11:30 a.m.

The objective of this session is to describe pharmacy practice capacity for meeting contemporary medication-related needs for Minnesota and the United States. Findings from National Pharmacist Workforce Surveys and Minnesota Pharmacist Workforce Surveys will be described and discussed.

About Our Speaker: Jon C. Schommer, RPh, PhD, is a professor at the University of Minnesota. He received his BS, MS, and PhD degrees from the University of Wisconsin – Madison. His research is focused upon the provision, use, and evaluation of drug products and pharmacist services. He recently completed the National Consumer Survey on the Medication Experience -- a study of over 36,000 individuals.

There is no cost for MPhA members to attend this program. The fee for nonmembers is $25 per person.

View Full Details


GRAPh/MPhA Town Hall

Thursday, May 10, 2018 • 5:30-8 p.m.
Timberlake Lodge, Grand Rapids, Minn.

Join your colleagues in Northern Minnesota for a chance to network, learn and share with one another while having your voices heard! GRAPh’s host and President is MPhA member Heather Bibeau of Bigfork Valley Hospital & Clinics. You’ll have the opportunity to mix, mingle and visit with exhibitors while sharing fellowship before the dinner program. We are pleased to announce that MPhA President-Elect Jason Varin and Interim Executive Director Marsha Millonig will provide an update on Minnesota Pharmacy’s advocacy efforts in 2018 and lead a Town Hall. You can also share your thoughts and ideas for both future GRAPh and MPhA events. We look forward to seeing you there!

Advancing MN Pharmacy: 2018 Advocacy Accomplishments
In this session, you will receive an update on PATF and Public Affairs activities and plans and have the opportunity to ask questions about the advocacy agenda.

After participating in this session, attendees will be able to:

  • List the Pharmacy Advocacy Task Force's 2018 legislative initiatives.
  • List the MPhA’s 2018 legislative initiatives.
  • List three ways you will become involved in moving this agenda forward.

Register Online


MPhA Leadership Summit and House of Delegates Meeting: Traveling the Road Forward

Thursday, May 31, 2018 • 8 a.m.-6:30 p.m. at Midland Hills Country Club, Roseville

The 2018 Leadership Summit and House of Delegates Meeting will be inspirational and motivational and provide you with the opportunity to network, learn and share with your peers throughout the day. The morning program will feature invigorating messages of creating change and professional advancement, tips for working across generational differences, and insights into succession planning to achieve your professional advancement goals.

We will share MPhA and pharmacy’s advocacy successes in the afternoon and be challenged to lay the groundwork for future advocacy initiatives to enable pharmacists to meet the health needs of Minnesota communities. During the House of Delegates, you will hear about the State of MPhA from leadership, discuss policy proposals and new business and install MPhA’s new leadership for the year. We’ll close our day with a networking reception honoring our Past Presidents and MPhA volunteers. The day is designed to provide us with a glimpse of how far we have come to advance patient care and practice and where we need to go next.


2018 Readmissions Action Learning Day: "Working Together to Make Readmissions Rare"

Monday, April 30, 2018 from 8:30 a.m. to 5:00 p.m.
Hilton MSP Airport Mall of America, Bloomington, MN

Lake Superior Quality Innovation Network invites you to register for the 2018 Readmissions Action Learning Day: "Working Together to Make Readmissions Rare." Learn together with your community peers and develop collaborative approaches to improving quality of care and quality of life by keeping patients healthy and safe at home. Sessions will highlight innovative and evidence-based strategies for collaborative approaches to improving coordination with care partners, designing a better care experience, engaging with patients and providers in new ways, and addressing root causes of hospital readmissions.

Registration Fees $50 (including lunch)

Register Online

National News

Update on Federal Provider Status Legislation

From APhA Email, April 11: APhA Executive Vice President Tom Menighan reports that congressional support for H.R. 592, the Pharmacy and Medically Underserved Areas Enhancement Act, continues to grow with nearly 60% of the House signed on as cosponsors. On April 11, the House Energy and Commerce Committee looked at numerous pieces of legislation during its third hearing on our Nation’s opioid crisis. This hearing was focused on ways the Medicare and Medicaid program can be improved to better deal with the epidemic.

Menighan said, “As you know, pharmacists have been an underutilized resource in improving the care of patients, including those with chronic pain. Because Medicare does not cover pharmacists’ services, beneficiaries' access to the health care practitioner with the most medication-related education and training is limited, and restricted mainly to services related to medication dispensing.”

During the hearing, Representatives Brett Guthrie (R-KY) and Cathy McMorris Rodgers (R-WA) introduced letters from APhA and other national and state pharmacy organizations calling for the passage of H.R. 592 to help combat the opioid epidemic. Congresswoman McMorris Rodgers discussed pharmacists’ important role in helping address the opioid epidemic and the need for passage of H.R. 592.

“APhA continues our quest for passage of the Pharmacy and Medically Underserved Areas Enhancement Act (S. 109/H.R. 592), and we are working for its inclusion in opioid legislation being considered by the House and Senate,” Menighan stated, adding, “We appreciate your ongoing participation in this effort. If you have not done so, please reach out to your Members of Congress and tell them to include pharmacists in legislation helping to address the opioid crisis. We’ve made it easy for you to take action! It takes less than 2 minutes to send one of our prewritten emails. All you have to do is fill out your contact information, view the editable email, and click submit.”

As a reminder, more than half of Minnesota's congressional delegation has signed on to support S. 109/H.R. 592: Reps. Tom Emmer, Jason Lewis, Erik Paulsen, Collin Peterson and Tim Walz in the House and Sen. Amy Klobuchar.


Research Offers Clues for Improved Flu Vaccine Design

From Pharmacy Today, April 9: New research suggests that influenza vaccines that better target the influenza surface protein neuraminidase (NA) could provide broad protection against diverse influenza virus strains and reduce the severity of illness. For the study, published in Cell, researchers analyzed blood samples from people vaccinated against influenza and people diagnosed with either the 2009 H1N1 influenza virus or H3N2 influenza viruses. Read more.


Synthetic Cannabis Laced with Poison Appears in Midwest

From Pharmacy Today, April 9: Officials from the Centers for Disease Control and Prevention (CDC) are warning that 94 people have been presented to emergency departments in five states (including Wisconsin, Illinois and Missouri) with potentially life-threatening issues after using synthetic cannabinoids. Two patients have died so far. Lab testing indicates that at least 18 of the patients were exposed to brodifacoum, a highly lethal vitamin K antagonist anticoagulant that is used in commercial products to kill rodents and other pests. CDC has sent a team to help the Illinois Department of Public Health with its investigation into the outbreak; 89 cases have been reported in Illinois. Read more.